Dr. Karsten Fischer


Dr. Karsten Fischer is Memo Therapeutics AG CEO and a senior executive in the life science field. Prior to joining Memo Therapeutics AG, he was a partner of BioMedPartners AG, a renowned European Venture Capitalist in the field of biotechnology, medical technology and diagnostics, where he did several investments into successful companies. Previously, Dr. Fischer has been working for WestLB in the healthcare and chemicals sector where he was heading the equity capital markets team realizing large primary market transactions and the strategic analysis working on debt, M&A, and equity transactions. He started his career with Deutsche Venture Capital, an affiliate of Deutsche Bank, investing into bio- and medical technology companies. He then consulted large cap pharmaceutical companies with McKinsey&Company on sales and marketing strategies before he went to Sanofi Aventis being responsible for Sales Force and Marketing Excellence. He has a biochemistry and economics background and holds a Ph.D. in infection biology (MPI Infection Biology and Colorado State University, with distinction).